Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

Detalles Bibliográficos
Autores principales: Rosell, Rafael, Filipska, Martyna, Chaib, Imane, Lligé, David, Laguia, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511626/
https://www.ncbi.nlm.nih.gov/pubmed/33014853
http://dx.doi.org/10.3389/fonc.2020.01726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511626/
https://www.ncbi.nlm.nih.gov/pubmed/33014853
http://dx.doi.org/10.3389/fonc.2020.01726

Ejemplares similares